Clinical Trial Update: Clinical Study of Therapeutic Immunological Agent for EBV Lymphoproliferative Diseases [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for a Therapeutic Immunological Agent targeting EBV-related lymphoproliferative diseases, with the study currently not yet recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Active Epstein-barr Virus Infection
• Post-transplant Lymphoproliferative Disorders

Drugs mentioned

• Therapeutic Immunological Agent

Snippet

Sponsor: West China Hospital | Conditions: CAEBV (Chronic Active Epstein-Barr Virus Infection) Syndrome, PTLDs | Phase 1 | Status: NOT_YET_RECRUITING